ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,783, issued on Jan. 20, was assigned to HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (Braunschweig, Germany).
"PqsR inverse agonists" was invented by Christian Schutz (Braunschweig, Germany), Martin Empting (Braunschweig, Germany), Ahmed S. Ahmed (Braunschweig, Germany), Mostafa Hamed (Braunschweig, Germany), Rolf W. Hartmann (Braunschweig, Germany), Teresa Rohrig (Braunschweig, Germany), Andreas M. Kany (Braunschweig, Germany) and Anna K. Hirsch (Braunschweig, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compounds according to general formula (I), which acts as an inverse agonist of PqsR (the currently...